SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001209191-23-049027
Filing Date
2023-09-11
Accepted
2023-09-11 19:36:37
Documents
2
Period of Report
2023-09-09

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 2175
2 POA DOCUMENT poa.txt EX-24 4701
  Complete submission text file 0001209191-23-049027.txt   8352
Mailing Address 300 ELLIOTT AVE WEST SUITE 500 SEATTLE WA 98119-4114
Business Address
Loewy Caroline M (Reporting) CIK: 0001367451 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-39866 | Film No.: 231248775

Mailing Address 142 NORTH CEDROS AVENUE, SUITE B SOLANA BEACH CA 92075
Business Address 142 NORTH CEDROS AVENUE, SUITE B SOLANA BEACH CA 92075 (858) 925-8215
eFFECTOR Therapeutics, Inc. (Issuer) CIK: 0001828522 (see all company filings)

IRS No.: 853306396 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations